Revival Products, Inc.
Letter data
- Company
- Revival Products, Inc.
- Recipient
- Ms. Suzanne S. Tabor | President | Revival Products, Inc. | 200 Peddycord Park Ct | Kernersville | , | NC | 27284-9827 | United States
- Issue date
- 2024-08-05
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations – East Division 3
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 606640
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Revival Products, Inc.
MARCS-CMS 606640 —
August 05, 2024
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
Via Email
Product:
Dietary Supplements
Recipient:
Recipient Name
Ms. Suzanne S. Tabor
Recipient Title
President
Revival Products, Inc.
200 Peddycord Park Ct
Kernersville
,
NC
27284-9827
United States
Issuing Office:
Office of Human and Animal Food Operations – East Division 3
United States
Secondary Issuing Offices
United States
Dear Ms. Tabor:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter CMS #606640 dated August 14, 2020. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
LCDR N’Jere English, Ph.D.
Compliance Officer
Office of Human and Animal Foods, East Division 3
Office of Regulatory Affairs
U.S. Food and Drug Administration
Content current as of:
08/05/2024
Regulated Product(s)
Dietary Supplements